Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001957912-25-000007·Baselake Partners, LP
Schedule 13G ownership disclosure
NEUPHORIA THERAPEUTICS INC
Common Stock, $0.00001 par value per share · CUSIP: 64136E102
Event date: 2025-10-27
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Baselake Partners, LP
Shares: 222,222 · Class: 9.4%
- Baselake Management, LLC
Shares: 222,222 · Class: 9.4%
- David Paolella
Shares: 222,222 · Class: 9.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001957912-25-000007
- Form type
- SCHEDULE 13G
- Filer
- Baselake Partners, LP
- CIK
- CIK 1957912
- Filed
- Oct 31, 2025
- Reporting period
- Oct 27, 2025
- Description
- Schedule 13G beneficial ownership